Who we are


Postbiotica is a spinoff of the University of Milan and was founded in January 2016.

Logo SpinOff - Università Degli Studi di Milano

It has already secured funding necessary for the initial developmental plan.

Postbiotica is proprietary of a new technology capable of modulating the type of metabolites generated during bacterial fermentation.

These metabolites called postbiotics have distinct immunomodulatory properties.

Prof Maria Rescigno

Maria Rescigno

Professor University of Milan – Director Immunotherapy Programme European Institute of Oncology.

World leader expert in mucosal immunology120 studies published (Science, Nature Immunol., Immunity, ecc.)

More than 20 years experience in host-microbe interactions.

Download Maria Rescigno CV